Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription 19.12.2011 1 Am J Surg 2 Am J Surg Pathol 1 Anticancer Drugs 1 Br J Cancer 1 Cancer Chemother Pharmacol 2 Cancer Lett 3 Cancer Res 1 Curr Opin Obstet Gynecol 8 Eur J Gynaecol Oncol 11 Gynecol Oncol 1 Histopathology 1 Hum Pathol 8 Int J Gynecol Pathol 2 Int J Oncol 3 J Clin Oncol 1 Lancet Oncol 2 Obstet Gynecol 2 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. PARSON EN , Lentz S, Russell G, Shen P, et al
   Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms.
   Am J Surg. 2011;202:481-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Am J Surg Pathol

2. OZSAN N , Bedke BJ, Law ME, Inwards DJ, et al
   Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
   Am J Surg Pathol. 2011;35:1691-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. KURMAN RJ , Vang R, Junge J, Hannibal CG, et al
   Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
   Am J Surg Pathol. 2011;35:1605-14.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Anticancer Drugs

4. HWANG JH , Yoo HJ, Lim MC, Seo SS, et al
   Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.
   Anticancer Drugs. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Br J Cancer

5. TAYLOR-HARDING B , Agadjanian H, Nassanian H, Kwon S, et al
   Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment.
   Br J Cancer. 2011 Dec 13. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Chemother Pharmacol

6. KANATANI I , Lin X, Yuan X, Manorek G, et al
   Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.
   Cancer Chemother Pharmacol. 2011;68:979-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Lett

7. GLOSS BS , Patterson KI, Barton CA, Gonzalez M, et al
   Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. SHAH PP , Kakar SS
   Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.
   Cancer Lett. 2011;311:66-76.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Res

9. ARORA HC , Jensen MP, Yuan Y, Wu A, et al
   Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SOMMARIVA M , De Cecco L, De Cesare M, Sfondrini L, et al
    TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
    Cancer Res. 2011;71:6382-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. DARSHAN MS , Loftus MS, Thadani-Mulero M, Levy BP, et al
    Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Curr Opin Obstet Gynecol

12. DONNEZ J , Squifflet J, Donnez O
    Minimally invasive gynecologic procedures.
    Curr Opin Obstet Gynecol. 2011;23:289-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Eur J Gynaecol Oncol

13. FENZL V , Prkacin I, Skrtic A
    Malignant melanoma ovarian metastasis mimicking acute tuboovarian abscess.
    Eur J Gynaecol Oncol. 2011;32:582-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ARNOGIANNAKI N , Grigoriadis C, Zygouris D, Terzakis E, et al
    Proliferative Brenner tumor of the ovary. clinicopathological study of two cases and review of the literature.
    Eur J Gynaecol Oncol. 2011;32:576-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. PARK ST , Song MJ, Lee CW, Lee AW, et al
    Synchronous clear cell adenocarcinoma of the cervix and endometrioid carcinoma of the endometrium.
    Eur J Gynaecol Oncol. 2011;32:573-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. VOUZA E , Kairi-Vassilatou E, Kleanthis CK, Hasiakos N, et al
    A rare ovarian Leydig cell tumor (hilar type) causing virilization in a postmenopausal woman.
    Eur J Gynaecol Oncol. 2011;32:557-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. HASEGAWA E , Nishi H, Terauchi F, Isaka K, et al
    A case of squamous cell carcinoma arising from endometriosis of the ovary.
    Eur J Gynaecol Oncol. 2011;32:554-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. GOTTWALD L , Dukowicz A, Misiewicz B, Pasz-Walczak G, et al
    An extremely rare presentation of relapse in endometrioid endometrial adenocarcinoma: isolated metastases to the tibia and humerus. Case report and review of the literature.
    Eur J Gynaecol Oncol. 2011;32:547-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. DEL RIO P , Dell'Abate P, Sianesi N, Fumagalli M, et al
    Right colon laparoscopic resection with three-trocar access and associated gynecological procedures in patients with colorectal cancer and ovarian metastases.
    Eur J Gynaecol Oncol. 2011;32:509-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. WALTER AC , Manahan KJ, Geisler JP
    Total colectomy in primary ovarian cytoreduction.
    Eur J Gynaecol Oncol. 2011;32:487-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Gynecol Oncol

21. STAVRAKA C , Ford A, Ghaem-Maghami S, Crook T, et al
    A study of symptoms described by ovarian cancer survivors.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SUNDAR S , Wu J, Hillaby K, Yap J, et al
    A systematic review evaluating the relationship between Progression free survival and Post Progression survival in advanced ovarian cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. SCHUMMER M , Drescher C, Forrest R, Gough S, et al
    Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
24. MARKMAN M
    Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
25. BARLIN JN , Yu C, Hill EK, Zivanovic O, et al
    Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. WHITWORTH JM , Londono-Joshi AI, Sellers JC, Oliver PJ, et al
    The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BURGER RA
    Advances in ovarian cancer disease control.
    Gynecol Oncol. 2012;124:5-9.
    PubMed     Text format     Related articles   
    
    
    
28. VERGOTE I , Leunen K, Amant F
    Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?
    Gynecol Oncol. 2012;124:1-2.
    PubMed     Text format     Related articles   
    
    
    
29. HYMAN DM , Zhou Q, Arnold AG, Grisham RN, et al
    Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HENRETTA MS , Anderson CL, Angle JF, Duska LR, et al
    It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.
    Gynecol Oncol. 2011;123:342-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. DIZON DS , Sill MW, Gould N, Rubin SC, et al
    Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study.
    Gynecol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Histopathology

32. STEWART CJ , Crook ML, Manso L
    Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
    Histopathology. 2011;59:73-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Hum Pathol

33. KONOPKA B , Janiec-Jankowska A, Kwiatkowska E, Najmola U, et al
    PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
    Hum Pathol. 2011.
    PubMed     Text format     Related articles   
    
    
    

    
    Int J Gynecol Pathol

34. GANESAN R , Hirschowitz L, Baltrusaityte I, McCluggage WG, et al
    Luteinized adult granulosa cell tumor--a series of 9 cases: revisiting a rare variant of adult granulosa cell tumor.
    Int J Gynecol Pathol. 2011;30:452-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. BRADY A , Al-Kalbani M, Al Rawahi T, Nagar H, et al
    Postirradiation primary vaginal angiosarcoma with widespread intra-abdominal metastasis.
    Int J Gynecol Pathol. 2011;30:514-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. STEWART CJ , Crook ML, Lacey J, Louwen K, et al
    Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
    Int J Gynecol Pathol. 2011;30:484-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. ROTH LM , Talerman A, Levy T, Sukmanov O, et al
    Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
    Int J Gynecol Pathol. 2011;30:442-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ZHANG X , Lu B
    Ovarian steroid cell tumor, not otherwise specified (NOS): an unusual case with myelolipoma.
    Int J Gynecol Pathol. 2011;30:460-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. YAMAMOTO S , Tsuda H, Shimazaki H, Takano M, et al
    Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma.
    Int J Gynecol Pathol. 2011;30:431-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. LEONHARDT K , Einenkel J, Sohr S, Engeland K, et al
    p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Int J Gynecol Pathol. 2011;30:417-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. ALVARADO-CABRERO I , Valencia-Cedillo R, Mohs-Alfaro M, De Anda-Gonzalez J, et al
    Ovarian dysgerminoma associated with fibrosarcoma: a case report.
    Int J Gynecol Pathol. 2011;30:466-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J Oncol

42. GAO J , Yang X, Yin P, Hu W, et al
    The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
    Int J Oncol. 2011 Dec 12. doi: 10.3892/ijo.2011.1293.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. SORBE B , Graflund M, Nygren L, Horvath G, et al
    A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation.
    Int J Oncol. 2011 Dec 7. doi: 10.3892/ijo.2011.1286.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Oncol

44. LI HK , Harding V, Williamson R, Blagden S, et al
    Cerebral Sinus Thrombosis and Leptomeningeal Carcinomatosis in a Patient With Ovarian Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
45. VIANA LS , Tsunoda AT, Nunes JS, Fregnani JH, et al
    Preservation of Pregnancy in a Patient With Acute Abdominal Pain Secondary to Advanced and Hemorrhagic Yolk Sac Tumor of the Right Ovary.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
46. ROHSBACH D , Trillsch F, Regier M, Choschzick M, et al
    Malignant transformation of a serous borderline tumor and early metastasis of associated low-grade serous carcinoma detected on screening mammography.
    J Clin Oncol. 2011;29:e763-5.
    PubMed     Text format     Related articles   
    
    
    

    
    Lancet Oncol

47. KELEMEN LE , Kobel M
    Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma.
    Lancet Oncol. 2011;12:1071-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Obstet Gynecol

48. TIMMERMAN D , Van Calster B, Vergote I, Van Hoorde K, et al
    Performance of the American College of Obstetricians and Gynecologists' Ovarian Tumor Referral Guidelines With a Multivariate Index Assay.
    Obstet Gynecol. 2011;118:1179-1181.
    PubMed     Text format     Related articles   
    
    
    
49. SAWAYA GF , Jacoby V
    Performance of the american college of obstetricians and gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
    Obstet Gynecol. 2011;118:1178.
    PubMed     Text format     Related articles   
    
    
    

    
    Oncogene

50. ALBERTI C , Pinciroli P, Valeri B, Ferri R, et al
    Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. ZHAI Y , Iura A, Yeasmin S, Wiese AB, et al
    MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: